Rosiglitazone attenuates suppression of RXRα-dependent gene expression in inflamed liver

Journal of Hepatology

Volumn 46, Issue 1, 2007, Pages 115-123

  Ghose, Romi ^a   Mulder, Jaap ^a,b   von Furstenberg, Richard J ^a   Thevananther, Sundararajah ^a   Kuipers, Folkert ^b   Karpen, Saul J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Inflammation; JNK; Liver; Nuclear export; PPAR ; Rosiglitazone; RXR

Indexed keywords

CYTOCHROME P450 3A11; CYTOKINE; CYTOPLASM PROTEIN; DRUG METABOLIZING ENZYME; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NUCLEAR PROTEIN; RETINOID X RECEPTOR ALPHA; RNA; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL STRAIN HEPG2; CONTROLLED STUDY; FEEDING; GENE EXPRESSION; GENE REPRESSION; HEPATITIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER; LIVER CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SERUM;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; GENE EXPRESSION; HEPATITIS, ANIMAL; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; PPAR GAMMA; RETINOID X RECEPTOR ALPHA; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; THIAZOLIDINEDIONES;

EID: 34547108415     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.09.008     Document Type: Article

References (37)

1. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
2. Karpen S.J. Transcriptional regulation of hepatobiliary transporters. Landes Biosci (2003) 96-111
3. Schletter J., Heine H., Ulmer A.J., and Rietschel E.T. Molecular mechanisms of endotoxin activity. Arch Microbiol 164 (1995) 383-389
4. Crawford J.M., and Boyer J.L. Clinicopathology conferences: inflammation-induced cholestasis. Hepatology 28 (1998) 253-260
5. Trauner M., Fickert P., and Stauber R.E. Inflammation-induced cholestasis. J Gastroenterol Hepatol 14 (1999) 946-959
6. Nakamura J., Nishida T., Hayashi K., Kawada N., Ueshima S., Sugiyama Y., Ito T., Sobue K., and Matsuda H. Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. Biochem Biophys Res Commun 255 (1999) 143-149
7. Rizzardini M., Zappone M., Villa P., Gnocchi P., Sironi M., Diomede L., Meazza C., Monshouwer M., and Cantoni L. Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta. Hepatology 27 (1998) 703-710
8. Sturm E., Zimmerman T.L., Crawford A.R., Svetlov S.I., Sundaram P., Ferrara J.L., Karpen S.J., and Crawford J.M. Endotoxin-stimulated macrophages decrease bile acid uptake in WIF-B cells, a rat hepatoma hybrid cell line. Hepatology 31 (2000) 124-130
9. Geier A., Dietrich C.G., Voigt S., Kim S.K., Gerloff T., Kullak-Ublick G.A., Lorenzen J., Matern S., and Gartung C. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38 (2003) 345-354
10. Karpen S.J. Nuclear receptor regulation of hepatic function. J Hepatol 36 (2002) 832-850
11. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
12. Wu Y., Zhang X., Bardag-Gorce F., Robel R.C., Aguilo J., Chen L., Zeng Y., Hwang K., French S.W., Lu S.C., and Wan Y.J. Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol 65 (2004) 550-557
13. Wan Y.J., An D., Cai Y., Repa J.J., Hung-Po Chen T., Flores M., Postic C., Magnuson M.A., Chen J., Chien K.R., French S., Mangelsdorf D.J., and Sucov H.M. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20 (2000) 4436-4444
14. Zimmerman T.L., Thevananther S., Ghose R., Burns A.R., and Karpen S.J. Nuclear export of RXRalpha in response to IL-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281 (2006) 15434-15440
15. Li D., Zimmerman T.L., Thevananther S., Lee H.Y., Kurie J.M., and Karpen S.J. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 277 (2002) 31416-31422
16. Ghose R., Zimmerman T.L., Thevananther S., and Karpen S.J. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2 (2004) 4
17. Rocchi S., and Auwerx J. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Ann Med 31 (1999) 342-351
18. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
19. Castrillo A., and Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 20 (2004) 455-480
20. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
21. Dubuquoy L., Dharancy S., Nutten S., Pettersson S., Auwerx J., and Desreumaux P. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360 (2002) 1410-1418
22. Uchimura K., Nakamuta M., Enjoji M., Irie T., Sugimoto R., Muta T., Iwamoto H., and Nawata H. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology 33 (2001) 91-99
23. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., Oliver D., and Bacon B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand Rosiglitazone. Hepatology 38 (2003) 1008-1017
24. Guo Y.T., Leng X.S., Li T., Zhao J.M., and Lin X.H. Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats. World J Gastroenterol 10 (2004) 3419-3423
25. Itoh M., Adachi M., Yasui H., Takekawa M., Tanaka H., and Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16 (2002) 2382-2392
26. Timchenko N.A., Harris T.E., Wilde M., Bilyeu T.A., Burgess-Beusse B.L., Finegold M.J., and Darlington G.J. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol 17 (1997) 7353-7361
27. Trauner M., and Boyer J.L. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83 (2003) 633-671
28. Karpen S.J. Transcriptional regulation of sinusoidal transporters. In: Matern S., Boyer J., Keppler D., and Meier-Abt P. (Eds). Hepatobiliary transport: from bench to bedside (2001), Kluwer Academic, London 22-31
29. Sato O., Kuriki C., Fukui Y., and Motojima K. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J Biol Chem 277 (2002) 15703-15711
30. Tanaka T., Rodriguez de la Concepcion M.L., and De Luca L.M. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem Pharmacol 61 (2001) 1347-1355
31. Zhang Y., Sun X., Muraoka K., Ikeda A., Miyamoto S., Shimizu H., Yoshioka K., and Yamamoto K. Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites. J Biol Chem 274 (1999) 34657-34662
32. Hazra S., Xiong S., Wang J., Rippe R.A., Krishna V., Chatterjee K., and Tsukamoto H. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 279 (2004) 11392-11401
33. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., and Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7 (2001) 48-52
34. Abdelrahman M., Sivarajah A., and Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res 65 (2005) 772-781
35. Welch J.S., Ricote M., Akiyama T.E., Gonzalez F.J., and Glass C.K. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 100 (2003) 6712-6717
36. Marra F., DeFranco R., Robino G., Novo E., Efsen E., Pastacaldi S., Zamara E., Vercelli A., Lottini B., Spirli C., Strazzabosco M., Pinzani M., and Parola M. Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol 11 (2005) 4931-4938
37. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., Sponseller C.A., Hampton K., and Bacon B.R. Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand Rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol 38 (2003) 434-440